 Diabetic Retinopathy
"Diabetic Retinopathy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Disease of the RETINA as a complication of DIABETES MELLITUS. It is characterized by the progressive microvascular complications, such as ANEURYSM, interretinal EDEMA, and intraocular PATHOLOGIC NEOVASCULARIZATION.
| Descriptor ID |
D003930
|
| MeSH Number(s) |
C11.768.257 C14.907.320.382 C19.246.099.500.382
|
| Concept/Terms |
Diabetic Retinopathy- Diabetic Retinopathy
- Diabetic Retinopathies
- Retinopathies, Diabetic
- Retinopathy, Diabetic
|
Below are MeSH descriptors whose meaning is more general than "Diabetic Retinopathy".
Below are MeSH descriptors whose meaning is more specific than "Diabetic Retinopathy".
This graph shows the total number of publications written about "Diabetic Retinopathy" by people in this website by year, and whether "Diabetic Retinopathy" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 1 | 1 | | 2000 | 3 | 0 | 3 | | 2002 | 1 | 1 | 2 | | 2003 | 2 | 2 | 4 | | 2004 | 2 | 1 | 3 | | 2005 | 1 | 1 | 2 | | 2006 | 5 | 3 | 8 | | 2007 | 0 | 1 | 1 | | 2008 | 4 | 1 | 5 | | 2009 | 4 | 1 | 5 | | 2010 | 7 | 2 | 9 | | 2011 | 1 | 1 | 2 | | 2012 | 5 | 0 | 5 | | 2014 | 2 | 3 | 5 | | 2015 | 2 | 1 | 3 | | 2016 | 5 | 1 | 6 | | 2017 | 2 | 0 | 2 | | 2018 | 8 | 1 | 9 | | 2019 | 4 | 2 | 6 | | 2020 | 5 | 3 | 8 | | 2021 | 4 | 2 | 6 | | 2022 | 7 | 0 | 7 | | 2023 | 11 | 0 | 11 | | 2024 | 8 | 1 | 9 | | 2025 | 3 | 2 | 5 | | 2026 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Diabetic Retinopathy" by people in Profiles.
-
Chen NC, Shah VN, McQueen RB. Time in Range and Incident Diabetic Retinopathy: Clinical and Economic Evidence From Real-World Type 1 Diabetes Care. J Clin Endocrinol Metab. 2026 Mar 17; 111(4):e1146-e1152.
-
Shah VN, Xu Y, Dabiri Y, Mohanadas HP, Cheng A, Dunn TC. Association of HbA1c and an updated glucose management indicator (uGMI) with incident diabetic retinopathy in adults with type 1 diabetes: a longitudinal study. Diabetologia. 2026 Mar; 69(3):610-617.
-
Nam MH, Nahomi RB, Suk J, Panja S, Smith WC, Shan Y, Fort PE, Nagaraj RH. DJ-1 Protects Human Retinal Endothelial Cells From Diabetes-Related Conditions and Prevents Ischemic Damage in Mouse Retinal Capillaries. Invest Ophthalmol Vis Sci. 2025 Nov 03; 66(14):8.
-
Arthur E, Ravichandran S, Rothstein A, Brown K, Jonnadula GB, Murchison CF, Grant MB. Retinal Mid-Peripheral Capillary Free Zones Are Enlarged in Diabetic Patients With No Evidence of Clinical Retinopathy. Transl Vis Sci Technol. 2025 Jul 01; 14(7):10.
-
Hartman GD, Sishtla K, Kpenu EK, Mijit M, Muniyandi A, Jo HN, Junge HJ, Shaw A, Bischof D, Liu S, Wan J, Kelley MR, Corson TW. Ref-1 redox activity modulates canonical Wnt signaling in endothelial cells. Redox Biol. 2025 06; 83:103646.
-
Hartman GD, Muniyandi A, Sishtla K, Kpenu EK, Miller WP, Kaplan BA, Kim LA, Liu S, Wan J, Qi X, Boulton ME, Kelley MR, Corson TW. Ref-1 redox activity regulates retinal neovascularization by modulating transcriptional activation of HIF-1a. FASEB J. 2025 Feb 15; 39(3):e70348.
-
Rodriguez SM, Hamill EB, Sundaresan A, Guffey D, Weng CY. Comparing Teleretinal Screening-Identified Diabetic Retinopathy With Diabetic Nephropathy and Other Markers of Systemic Disease. Int Ophthalmol Clin. 2025 Jan 01; 65(1):27-33.
-
Bhambhwani V, Whitestone N, Patnaik JL, Ojeda A, Scali J, Cherwek DH. Feasibility and Patient Experience of a Pilot Artificial Intelligence-Based Diabetic Retinopathy Screening Program in Northern Ontario. Ophthalmic Epidemiol. 2025 Oct; 32(5):518-524.
-
Borchert GA, Kiire CA, Stone NM, Akil H, Gkika T, Fischer MD, Xue K, Cehajic-Kapetanovic J, MacLaren RE, Charbel Issa P, Downes SM, De Silva SR. Real-world six-month outcomes in patients switched to faricimab following partial response to anti-VEGF therapy for neovascular age-related macular degeneration and diabetic macular oedema. Eye (Lond). 2024 Dec; 38(18):3569-3577.
-
Sterling JK, Rajesh A, Droho S, Gong J, Wang AL, Voigt AP, Brookins CE, Lavine JA. Retinal perivascular macrophages regulate immune cell infiltration during neuroinflammation in mouse models of ocular disease. J Clin Invest. 2024 Aug 29; 134(20).
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|